Genstruct and Gene Logic Collaborate on Systems Toxicology
February 25, 2009
SAN FRANCISCO, CAMBRIDGE, Mass. and GAITHERSBURG, Md., Feb. 25 -- (CHI's Molecular Medicine Tri-Conference) - Genstruct Inc., a systems biology company focused on identifying molecular mechanisms, networks and biomarkers to better develop novel therapeutics, molecular diagnostics and patient-specific therapies, today announced that it has signed a partnership agreement with Gene Logic, an Ocimum Biosolutions company, [...]
Researchers Develop GPC-LC-MS/MS Method to Screen for 31 Mycotoxins in Edible Oil
February 25, 2009
Comprehensive Mycotoxin Screen Enables Compliance with New Regulations at Lower Cost MOUNTAIN VIEW, Calif.--Pickering Laboratories today announced that researchers at the Munich Technical University and Bavarian Health and Food Safety Authority have developed an innovative, comprehensive mycotoxin screening method based on the use of LCTech’s GPC ULTRA gel permeation chromatography instrument. Distributed by Pickering Laboratories [...]
February 25, 2009
Riverview, FL February 2009 Both organizations have demonstrated their commitment to serving the needs of ethanol and biodiesel laboratories with their own portfolios of complementary instruments, reagents and technical support. This cooperative now offers these labs and, most importantly, those performing analytical testing, the most comprehensive solutions available—with the singular goal of helping them conform [...]
Luminos and University of Michigan Patent New Demethylase Assay Technology
February 25, 2009
ANN ARBOR, Mich.--Two scientists at Luminos, LLC (www.LuminosAssays.com) and Professor Ray Trievel from the Department of Biological Chemistry at the University of Michigan (https://www.chembio.umich.edu/people/trievel.html) filed a US patent application that relates to a new, novel method to detect demethylase enzyme activity. Demethylase enzymes remove methyl groups attached to DNA, proteins and toxins and have become [...]
February 25, 2009
FREMONT, Calif., Feb. 25 -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art gene expression, genotyping, cell biology and stem cell research systems, today announced positive data on the company's SmartChip(TM) Real-Time PCR System. These validation results were presented today by WaferGen scientists and collaborative researchers from the University of Pittsburgh [...]
CEM & EspiKem Form Strategic Partnership to Facilitate Joint Training and Research Projects
February 25, 2009
(Matthews, North Carolina) February 25, 2009 - CEM Corporation, a leading global provider of microwave laboratory instrumentation, is pleased to announce the start of a collaboration between the Company and EspiKem, SRL, a contract research organization specializing in the syntheses of peptides and other biomolecules and the development of various bioassays. EspiKem will offer specialized [...]
February 25, 2009
Genedata, a leading provider of in-silico solutions for pharmaceutical R&D and related life sciences, today announced the extension of a biomarker discovery collaboration with Syngenta, a leading global agrochemical company. Syngenta has added the Genedata Expressionist Refiner MS module for LC-MS and GC-MS metabolomic raw data processing and analysis to their existing Genedata Expressionist system. [...]
Thermo Fisher Scientific Introduces Automated Pipette Tips
February 25, 2009
New Molecular BioProducts BioRobotix® 384-Well Automated Pipette Tips for use on Velocity11 Liquid Handling Workstations San Diego, CA (February 25, 2009) – Thermo Fisher Scientific Inc., the world leader in serving science, has announced today the addition of its new 384-well pipette tips for the Velocity11 VPrep® and Bravo™ liquid handling workstations. All pipette tips [...]
February 25, 2009
Battelle Ventures, LP, has spun out Hepregen Corporation from the Massachusetts Institute of Technology (MIT), with a commitment of a $5-million Series A investment from the fund and its Tennessee affiliate, Innovation Valley Partners. The company, which is developing bioengineered solutions for drug development, received the first $3 million from the funds last summer, leaving [...]
Nanogen and HandyLab Conclude License and Supply Agreements for Real-Time PCR Diagnostics
February 25, 2009
Nanogen, Inc. (Nasdaq: NGEN), developer of molecular and rapid diagnostic products, announced today that it has expanded its partnership with HandyLab, Inc. by signing a licensing and supply agreement for use of the company’s proprietary Minor Groove Binder (MGB) Probe technology and synthetic nucleic acid chemistries, including dyes and quenchers, for use in in vitro [...]

